Mirabaud & Cie’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$218K Buy
+1,500
New +$207K 0.08% 50
2025
Q1
– Sell
-15,059
Closed -$1.5M – 63
2024
Q4
$1.5M Sell
15,059
-22,470
-60% -$2.32M 0.48% 34
2024
Q3
$4.26M Sell
37,529
-6,741
-15% -$801K 1.23% 19
2024
Q2
$5.48M Sell
44,270
-3,085
-7% -$397K 1.85% 17
2024
Q1
$6.25M Sell
47,355
-4,869
-9% -$600K 2.2% 15
2023
Q4
$5.69M Buy
+52,224
New +$5.42M 1.9% 19

Other funds holding MRK

Mirabaud & Cie's MRK Position: Q3 2026 in Review

Mirabaud & Cie opened a new position in Merck (MRK) in Q3 2026: 1,500 shares worth $218K. The stake represents 0.08% of the portfolio and ranks #50 among its holdings. This is a return to the name: Mirabaud & Cie previously reported a position in MRK as recently as Q4 2024.

Mirabaud & Cie first reported a position in MRK in Q4 2023 and has held it in 6 quarters since. The position peaked at $6.25M in Q1 2024. 1,788 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Mirabaud & Cie held 1,500 shares of Merck worth $218K as of Q3 2026.
  • Merck was a new Mirabaud & Cie position in Q3 2026.
  • Merck made up 0.08% of Mirabaud & Cie's portfolio in Q3 2026, its #50 holding.
  • Mirabaud & Cie first reported a position in Merck in Q4 2023 and has held it in 6 quarters since.
  • Mirabaud & Cie's Merck position peaked at $6.25M in Q1 2024.
  • 1,788 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Mirabaud & Cie's 13F filing for Q3 2026, filed 27 Oct 2026.